Search Results for “medical device” – Page 67 – media

Countdown！Ddu to attend the America AACC

The 69th Annual Scientific Meeting and Clinical Lab Exposition (AACC) will be held in Orlando, USA from August 1st to August 3rd, 2017.
- Source: Ddu
- 665
- July 31, 2017
AACC Exhibitions & Activities medical device
Five Tips to Create Better Quotes

Offering a quotation to a client is not always as simple as it sounds and may take some time to master. How can we swiftly attract clients and ensure effective communication with potential customers in a short amount of time?
- Source: Ddu
- 851
- July 25, 2017
Ddu College quotation
Global Hemodialysis Consumables Market Analysis

As the most potential market in china, Hemodialysis market appears a large revenue space. With the opening of private hemodialysis services, private economy in the hemodialysis industry is about to take a ”Golden era”.
- Source: Ddu
- 591
- June 24, 2017
hemodialysis consumables Market Reports
Current Situation and Development Trends of China’s Rehabilitation Consumables Market

With the improvement of living standards and the enhancement of health consciousness, people’s investment in healthcare has been increased. In recent years, the scale of China's rehabilitation consumables market has been increased year by year.
- Source: Ddu
- 702
- May 23, 2017
Market Reports rehabilitation consumables
Could Drugdu.com (Ddu) be the next unicorn after Didi and Baidu in 2017？

In which industry is the next unicorn company most likely to be born into? With the arrival of an aging society, medical trade is regarded as the industry with the most potential to produce a unicorn company.
- Source: Ddu
- 1,142
- May 20, 2017
Ddu News innovation traditional
Barco showcases new products at CCR2024, adding momentum to precision medicine

The 31st Radiology Academic Conference of the Chinese Medical Association (CCR2024) was held at the Shanghai World Expo Center from November 14th to 17th. Barco showcased its new Coronis OneLook 32MP multimodal diagnostic imaging display, integrated reading center, and multiple radiology displays at the booth, bringing cutting-edge technology and outstanding products to the Chinese precision medicine market with updated and more comprehensive solutions. New product One Look 32MP unveiled, showcasing higher standards in the medical display field The display is a bridge connecting radiologists and medical imaging, and its performance directly affects the accuracy of doctors’ capture, interpretation, and diagnosis of image details. At this conference, Barco unveiled its new Coronis OneLook 32MP multimodal fusion display, bringing more refined solutions to the Chinese medical market. The Coronis OneLook 32MP multimodal fusion display is Barco’s industry-leading medical display solution, featuring a 32MP ultra high definition resolution and a 33 inch large ...
- Source: drugdu
- 47
- November 20, 2024
Johnson & Johnson’s first PFA product is approved by the FDA for marketing

Recently, Johnson & Johnson announced that it has obtained approval from the U.S. Food and Drug Administration (FDA) for its Varipulse pulsed field ablation system for the treatment of drug-refractory paroxysmal atrial fibrillation. After obtaining approval, Johnson & Johnson became the third company in the United States to have PFA technology for the treatment of AFib, joining the ranks of Medtronic and Boston Scientific, and the three-way competition in the PFA market has officially begun. It is understood that the Varipulse pulsed field ablation system consists of the Varipulse ablation catheter and the TRUPULSE generator. Among them, the VARIPULSE ablation catheter was developed based on Johnson & Johnson’s previous mapping catheter LASSO catheter, which is a continuation of the LASSO catheter technology, which further demonstrates Johnson & Johnson’s deep technical reserves in the catheter field. The Varipulse ablation catheter has 10 electrodes on the ring tip, and the ring tip ...
- Source: drugdu
- 41
- November 18, 2024
Johnson&Johnson’s first PFA product receives FDA approval for market launch

Recently, Johnson&Johnson announced that it has received approval from the US Food and Drug Administration (FDA) for its Varipulse pulsed field ablation system, which can be used to treat drug-resistant paroxysmal atrial fibrillation. After obtaining approval, Johnson&Johnson became the third company in the United States to have PFA technology for treating AFib, joining the ranks of Medtronic and Boston Scientific, and the PFA market’s top three competition officially opened. With the support of an ace, Johnson&Johnson has strong competitive strength It is understood that the Varipulse pulsed field ablation system consists of a Varipulse ablation catheter and a TRUPULSE generator. Among them, the VARIPULSE ablation catheter was developed based on Johnson&Johnson’s previous mapping catheter LASSO catheter, which is a continuation of LASSO catheter technology and further demonstrates Johnson&Johnson’s deep technical reserves in the catheter field. The Varipulse ablation catheter has 10 electrodes on the annular tip, and the size of ...
- Source: drugdu
- 57
- November 14, 2024
Four innovative pharmaceutical companies have completed a new round of financing! 3 from China

According to the Instant Drug Database, last week (November 4th to November 10th), at least four emerging companies dedicated to innovative drug research and development worldwide announced the completion of a new round of financing, including three Chinese companies. These emerging companies that have gained favor in the capital market are developing drug types such as gene therapy drugs, iPSC cell therapy drugs, peptide vaccines, and antibody conjugated drugs (ADCs) with dual payloads. Kanglin Biotechnology Financing round: Series A Financing amount: 150 million yuan On November 8th, Kanglin Biotechnology (Hangzhou) Co., Ltd. (referred to as “Kanglin Biotechnology”) announced the completion of a 150 million yuan Series A financing, jointly invested by Zhejiang Province’s “4+1” Biomedical and High end Device Industry Fund and old shareholder Zhejiang Miyin Investment Management Co., Ltd. Kanglin Biology was founded in 2015, focusing on the R&D and commercialization of innovative drugs for gene therapy, targeting diseases ...
- Source: drugdu
- 52
- November 13, 2024
Imaging giant, newly established production base

Recently, Yum! Brands announced the establishment of a new manufacturing base (B-15, Sector 60 Noida Uttar Pradesh) in New Delhi, created and managed by its subsidiary Esaote Asia Pacific Diagnostic Private Limited, to further strengthen its business in India. Yum! Brands’ new production base will produce a full range of “Made in India” advanced ultrasound products for the Indian market, including My Lab ™ A、My Lab ™ E Series and compact portable ultrasound devices will be launched on the market shortly after completing regulatory and quality assurance processes with local authorities. Data shows that Yum! Brands is headquartered in Italy, with its main research and development production bases located in Italy, as well as production bases in the Netherlands and China. In the field of ultrasound imaging, Baisheng Medical Group has mastered the core technology of the entire industry chain and has the ability to independently develop core components. It ...
- Source: drugdu
- 55
- November 13, 2024

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.